You have 9 free searches left this month | for more free features.

Bemarituzumab

Showing 1 - 10 of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastric Cancer, Gastroesophageal Junction Cancer Trial in Japan, Korea, Republic of, Taiwan (Bemarituzumab, CAPOX, SOX)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Bemarituzumab
  • +3 more
  • Northport, New York
  • +13 more
Jan 4, 2023

Recurrent Bladder Cancer Trial (FPA144)

No longer available
  • Recurrent Bladder Cancer
  • (no location specified)
Dec 9, 2021

Squamous-Cell Non-Small-Cell Lung Cancer Trial in Worldwide (Bemarituzumab, Docetaxel)

Recruiting
  • Squamous-Cell Non-Small-Cell Lung Cancer
  • Orange, California
  • +24 more
Jul 27, 2022

Gastric or Gastroesophageal Cancer Trial in Kawasaki-shi, Chuo-ku (FPA144)

Completed
  • Gastric or Gastroesophageal Cancer
  • Kawasaki-shi, Kanagawa, Japan
  • +1 more
Jun 13, 2023

Solid Tumors Trial (Bemarituzumab)

Recruiting
  • Solid Tumors
  • Bemarituzumab
  • Duarte, California
  • +54 more
Feb 1, 2023

Adenocarcinoma Trial in Chicago (Trastuzumab, ABT-806, Bemarituzumab)

Completed
  • Adenocarcinoma
  • Chicago, Illinois
    University of Chicago
Mar 15, 2021

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Bemarituzumab, Nivolumab, mFOLFOX6)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Bemarituzumab
  • +3 more
  • Phoenix, Arizona
  • +119 more
Feb 1, 2023

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Bemarituzumab, mFOLFOX6, Placebo)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Bemarituzumab
  • +2 more
  • Anchorage, Alaska
  • +140 more
Aug 11, 2022

Gastric Cancer Trial in Worldwide (Bemarituzumab, Placebo, Modified FOLFOX6)

Completed
  • Gastric Cancer
  • Bemarituzumab
  • +2 more
  • Tucson, Arizona
  • +188 more
Dec 15, 2022